SIRPA and myeloid neoplasm: In addition to the T-cell immune checkpoints, CD47 is the dominant MΦ checkpoint, which is overexpressed in myeloid malignancies and inhibits phagocytosis through “do not eat me” signals upon its binding to SIRPα on MΦs [54].